Given the central role of NF-κB in cancer progression and therapy resistance, the ability of WFA to suppress NF-κB activity could represent a critical mechanism by which it potentiates the efficacy of GC in treating pancreatic cancer. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.